CAS 1446144-04-2

6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-2,3,9-trimethyl-, (6S)-

CAS : 1446144-04-2

Formule : C₁₉H₁₈ClN₅OS

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 399.8971

Ref: IN-DA001JUL

(S)-2-(4-(4-Chlorophenyl)-2,3,9-Trimethyl-6H-Thieno[3,2-f][1,2,4]Triazolo[4,3-a][1,4]Diazepin-6-yl)Acetamide

CAS : 1446144-04-2

(S)-2-(4-(4-Chlorophenyl)-2,3,9-Trimethyl-6H-Thieno[3,2-f][1,2,4]Triazolo[4,3-a][1,4]Diazepin-6-yl)Acetamide

Degré de pureté : 99%

Masse moléculaire : 399.9g/mol

Ref: 54-OR1023963

(S)-CPI203

CAS : 1446144-04-2

(S)-CPI203

Degré de pureté : ≥98%

Masse moléculaire : 399.9g/mol

Ref: 54-BUP13055

(S)-CPI203

CAS : 1446144-04-2

CPI-203 is an effective BET bromodomain inhibitor (IC50: 37 nM for BRD4).

Formule : C₁₉H₁₈ClN₅OS

Degré de pureté : 99.01% - 99.92%

Couleur et forme : Solid

Masse moléculaire : 399.9

Ref: TM-T6026

CPI-203

CAS : 1446144-04-2

Degré de pureté : 98%

Masse moléculaire : 399.899993896484

Ref: 10-F861900

CPI 203

Produit contrôlé

CAS : 1446144-04-2

CPI 203 is an inhibitor of the protein polymerase chain. It blocks the progression of cells in the G2 phase of the cell cycle, preventing them from entering mitosis. This drug also inhibits viral replication by binding to and inhibiting cyclin-dependent kinases (CDKs), which are enzymes that regulate cellular division and proliferation. In addition, CPI 203 has been shown to inhibit cyclin D2, a regulator of G2/M transition and DNA damage repair. This product can be used for cancer treatment as well as for other diseases such as viral infections, diabetes, or Alzheimer's disease.

Formule : C₁₉H₁₈ClN₅OS

Degré de pureté : Min. 95%

Masse moléculaire : 399.9 g/mol

Ref: 3D-WHC14404